Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Virus Specific Cytotoxic T-Lymphocytes for the Treatment of CMV After Allogeneic Stem Cell Transplant: A Dose-Finding Trial

NCT00078533 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00078533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00078533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Virus Specific Cytotoxic T-Lymphocytes for the Treatment of CMV After Allogeneic Stem Cell Transplant: A Dose-Finding Trial
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2004
Completion date
June 30, 2011
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infections